Register

Chongqing Jingzhun Biotechnology Co., Ltd.

重庆精准生物技术有限公司
Get registeredChina • Asia
Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
Country
China
Region
Asia

Regulatory licences

  • DPL
    Name on licence: 重庆精准生物技术有限公司

Registered products

2 products
InjectionPujiaolunsai普基奥仑赛注射液本品体积约为50ml/袋。目标剂量为3.80×10^5～1.02×10^6个活的抗CD19 CAR-T细胞/kg体重，每个患者输注的总活的抗CD19 CAR-T细胞上限不超过1.02×10^8。InjectionPujiaolunsai普基奥仑赛注射液本品体积约为22ml/袋。目标剂量为3.80×10^5～1.02×10^6个活的抗CD19 CAR-T细胞/kg体重，每个患者输注的总活的抗CD19 CAR-T细胞上限不超过1.02×10^8。